1 research outputs found
Avonex Combination Trial in relapsing—remitting MS: rationale, design and baseline data
- Author
- AD Goodman
- Agresti A.
- Barkhof F.
- Beck RW
- Beck RW
- Besag J.
- Besl PJ
- BF Mandell
- Boers M.
- C. Hara-Cleaver
- Calabresi PA
- Clanet M.
- Cohen JA
- Cohen JA
- Currier RD
- DM Ivancic
- E. Fisher
- European Study Group on Interferon β-1b in Secondary Progressive MS.
- Fischer JS
- Fisher E.
- Fitzmaurice G.
- Flynn JA
- Frequin Stfm
- Frequin Stfm
- Furst DE
- Gasperini C.
- GJ Hutton
- Goodkin DE
- Goodkin DE
- H. Zhang
- Hartung HP
- JA Cohen
- Jacobs LD
- JE Perryman
- Johnson KP
- Jones KW
- KR Edwards
- Krapf H.
- Kremer JM
- Kremer JM
- Maini RN
- McDonald WI
- Moreland LW
- Morgan SL
- O'Dell JR
- PA Calabresi
- PB Imrey
- Polman CH
- PRISMS Study Group.
- Richert ND
- RJ Fox
- Roenigk HH
- Rudick R.
- Rudick RA
- Rudick RA
- Rudick RA
- S. Chakraborty
- Sandoval DM
- Santago P.
- Solari A.
- T. Eickenhorst
- TF Scott
- The IFNB Multiple Sclerosis Study Group The University of British Columbia MS/MRI Analysis Group.
- The IFNB Multiple Sclerosis Study Group.
- TT Skaramagas
- Tugwell P.
- Walker AM
- Weinblatt ME
- Weinblatt ME
- Weinblatt ME
- Wilke WS
- WL Felton
- Zivadinov R.
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study